N8: Dose-Intensive Chemotherapy Plus Biologics in the Treatment of Neuroblastoma.

Trial Profile

N8: Dose-Intensive Chemotherapy Plus Biologics in the Treatment of Neuroblastoma.

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Mar 2013

At a glance

  • Drugs Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Isotretinoin; Monoclonal antibody 3F8; Thiotepa; Topotecan; Vincristine
  • Indications Neuroblastoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Dec 2009 Actual end date (JAn 2007) added as reported by ClinicalTrials.gov.
    • 22 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top